HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Farasat Kazmi Selected Research

NUC-7738

12/2021The Novel Nucleoside Analogue ProTide NUC-7738 Overcomes Cancer Resistance Mechanisms In Vitro and in a First-In-Human Phase I Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Farasat Kazmi Research Topics

Disease

4Neoplasms (Cancer)
12/2021 - 11/2018
2Glioblastoma (Glioblastoma Multiforme)
01/2020 - 03/2019
1Lymphoma (Lymphomas)
07/2021
1Ovarian Neoplasms (Ovarian Cancer)
01/2021
1Ischemic Stroke
03/2018
1Stroke (Strokes)
03/2018

Drug/Important Bio-Agent (IBA)

1NucleotidesIBA
12/2021
1NucleosidesIBA
12/2021
1ProTidesIBA
12/2021
1NUC-7738IBA
12/2021
1Carrier Proteins (Binding Protein)IBA
12/2021
1Histidine (L-Histidine)FDA Link
12/2021
1EnzymesIBA
12/2021
1Histone Deacetylase InhibitorsIBA
07/2021
1AcetylesteraseIBA
07/2021
1Histones (Histone)IBA
07/2021
1Proteins (Proteins, Gene)FDA Link
07/2021
1Biomarkers (Surrogate Marker)IBA
07/2021
1Carboplatin (JM8)FDA LinkGeneric
01/2021
1NUC-1031IBA
01/2021
1PlatinumIBA
01/2021
1GoldIBA
01/2020

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2021
1Re-Irradiation
03/2019
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
11/2018
1Radiotherapy
11/2018
1Decompressive Craniectomy
03/2018
1Craniotomy
03/2018
1Decompression
03/2018